Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

HIV-1 resistance and trend analysis in newly diagnosed patients in Belgium.

Acta clinica Belgica - 1 Jan 2000

Muyldermans G, Sasse A

Abstract excerpt

A total of 1055 nucleotide sequences obtained from HIV patients diagnosed in 2008 and 2009 in Belgium were included in this prevalence study. The study population is a group of patients whose visit was considered by the clinician as the first contact with a Belgian AIDS reference centre or with another clinical centre experienced in HIV care. Prevalences of surveillance drug resistance mutations (SDRM) of 11·7%...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Algorithms
Share to Belgium
Share to Drug Resistance, Viral

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to HIV Infections

Share to HIV Protease Inhibitors

Share to Prevalence

Share to Reverse Transcriptase Inhibitors

Source

Identifiers

PMID: 24635391
DOI: 10.1179/0001551213Z.0000000001

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026. Manifest publication-graph-cohort-2026-09-06.1.

Source receipt: pubmed, retrieved 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

HIV-1 resistance and trend analysis in newly diagnosed patients in Belgium.PMID 24635391Read ↗

Prevalence and epidemiology of HIV type 1 drug resistance among newly diagnosed therapy-naive patients in Belgium from 2003 to 2006.Semantic proximity Read ↗

Trends and predictors of transmitted drug resistance (TDR) and clusters with TDR in a local Belgian HIV-1 epidemic.Semantic proximity Read ↗

Short communication: prevalence of HIV type 1 transmitted drug resistance in Slovenia: 2005-2010.Semantic proximity Read ↗

HIV-1 transmitted drug resistance in Slovenia and its impact on predicted treatment effectiveness: 2011-2016 update.Semantic proximity Read ↗

Ten years survey of primary HIV-1 resistance in Serbia: the occurrence of multiclass resistance.Semantic proximity Read ↗

Trends in antiretroviral therapy and prevalence of HIV drug resistance mutations in Sweden 1997-2011.Semantic proximity Read ↗

Analysis of HIV-1 diversity, primary drug resistance and transmission networks in Croatia.Semantic proximity Read ↗

Temporal Trends in HIV-1 Mutations Used for the Surveillance of Transmitted Drug Resistance.Semantic proximity Read ↗

Changes from 2000 to 2009 in the Prevalence of HIV-1 Containing Drug Resistance-Associated Mutations from Antiretroviral Therapy-Naive, HIV-1-Infected Patients in the United States.Semantic proximity Read ↗

National sentinel surveillance of transmitted drug resistance in antiretroviral-naive chronically HIV-infected patients in France over a decade: 2001-2011.Semantic proximity Read ↗

European recommendations for the clinical use of HIV drug resistance testing: 2011 update.Semantic proximity Read ↗

Increasing proportions of HIV-1 non-B subtypes and of NNRTI resistance between 2013 and 2016 in Germany: Results from the national molecular surveillance of new HIV-diagnosesSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.